Mexico - Delayed Quote • MXN Swedish Orphan Biovitrum AB (publ) (SOBIN.MX) Follow Compare 0.0000 -321.0738 (-100.00%) At close: December 16 at 8:35:32 AM CST Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for SOBIN.MX 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: SOBIN.MX View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Invitation: Sobi's Q4 and FY 2024 report Sobi Announces FDA Acceptance of New Drug Application for Avatrombopag (DOPTELET®) for the Treatment of Pediatric Immune Thrombocytopenia High Growth Tech Stocks To Watch This November 2024 Notice of Extraordinary General Meeting in Swedish Orphan Biovitrum AB (publ) Sobi to present new data across its immunology portfolio at the ACR Convergence 2024 David Meek is proposed as new Chair of the Board of Directors of Sobi New data for emapalumab in the treatment of macrophage activation syndrome to be presented at the ACR conference Pivotal VALIANT results presented at Kidney Week show pegcetacoplan treatment effect in patients with C3G / primary IC-MPGN Invitation: Sobi's Aspaveli® and the Phase 3 VALIANT data in Nephrology call Sobi Q3 2024 report: Strong growth and significant pipeline momentum High Growth Tech Stocks In Sweden With Promising Potential